CHIOME BIOSCIENCE: Confirmation

EDINETMay 14 03:12 ET · Announcements

CHIOME BIOSCIENCE: Quarterly Report - 21st Quarter 1st Quarter (2024/01/01 - 2024/03/31)

EDINETMay 14 03:12 ET · Announcements

Chiome Bioscience 1Q Parent Loss Y304.00M Vs Loss Y227.00M

Chiome Bioscience Inc. (4583.TO) Japan 1st Quarter Ended March 31 PARENT 2024 2023 Revenue Y129.00 mln Y169.00 mln Operating Profit (Y

Dow JonesMay 14 03:02 ET

CHIOME BIOSCIENCE: Financial Results Supplement 1st Quarter Fiscal Year 2024/12

JPXMay 14 03:00 ET · Announcements

CHIOME BIOSCIENCE: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending 2024/12 [Japanese GAAP] (unconsolidated)

JPXMay 14 03:00 ET · Announcements

GENDA, LaQuoria Drug Discovery, etc.

＜4579＞License agreement signed for the Middle East/North Africa region of LaQuolia Drug Discovery Gastric Acid Secretion Inhibitor tegoprazan ＜4583＞Number of shares to be issued from the 9th of mass exercise of Kaiom 20th Stock Acquisition Rights (with exercise price correction clauses), 361,200 shares ＜4882＞number of shares issued from the 4th of mass exercise of Perseus 28th Stock Acquisition Rights (with exercise price correction clauses), 290,500 shares ＜9166＞GENDA stock split, 2 shares ← 1 share 9229＞Sun Wells

Fisco JapanApr 23 18:30 ET